AQST Aquestive Therapeutics, Inc. Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

AQST [NASD]

Aquestive Therapeutics, Inc.

Healthcare | Biotechnology | USA

statements

Index	-	P/E	-	EPS (ttm)	-1.78	Insider Own	5.90%	Shs Outstand	33.59M	Perf Week	4.57%
Market Cap	175.79M	Forward P/E	-	EPS next Y	-1.76	Insider Trans	-9.75%	Shs Float	29.57M	Perf Month	-32.48%
Income	-49.90M	PEG	-	EPS next Q	-0.46	Inst Own	55.30%	Short Float	6.35%	Perf Quarter	0.00%
Sales	59.30M	P/S	2.96	EPS this Y	11.80%	Inst Trans	0.03%	Short Ratio	1.67	Perf Half Y	26.44%
Book/sh	-0.64	P/B	-	EPS next Y	-16.60%	ROA	-78.20%	Target Price	-	Perf Year	66.98%
Cash/sh	0.76	P/C	6.92	EPS next 5Y	-	ROE	241.10%	52W Range	1.41 - 10.00	Perf YTD	-9.62%
Dividend	-	P/FCF	-	EPS past 5Y	-36.50%	ROI	-106.20%	52W High	-47.40%	Beta	-
Dividend %	-	Quick Ratio	2.70	Sales past 5Y	90.00%	Gross Margin	68.60%	52W Low	273.05%	ATR	0.48
Employees	232	Current Ratio	3.00	Sales Q/Q	95.50%	Oper. Margin	-66.20%	RSI (14)	42.25	Volatility	6.49% 7.66%
Optionable	Yes	Debt/Eq	-	EPS Q/Q	91.50%	Profit Margin	-84.20%	Rel Volume	0.26	Prev Close	5.32
Shortable	Yes	LT Debt/Eq	-	Earnings	Nov 04 AMC	Payout	-	Avg Volume	1.12M	Price	5.26
Recom	1.80	SMA20	4.31%	SMA50	-23.14%	SMA200	6.05%	Volume	288,816	Change	-1.13%

Apr-22-19

Initiated

H.C. Wainwright

Buy

Jan-03-19

Initiated

Lake Street

Buy

$14

Aug-20-18

Initiated

RBC Capital Mkts

Outperform

$23

Aug-20-18

Initiated

JMP Securities

Mkt Outperform

$29

Oct-19-20 07:21AM	Aquestive Therapeutics, Inc. (NASDAQ:AQST): Is Breakeven Near? Simply Wall St. +6.96%
Oct-14-20 07:30AM	Aquestive Therapeutics to Announce Third Quarter Financial Results and Recent Business Highlights on November 4 and Host Conference Call on November 5 at 8:00 a.m. ET GlobeNewswire
Sep-30-20 11:00AM	Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Aquestive Therapeutics, Inc. (AQST) Investigation ACCESSWIRE +10.09%
Sep-29-20 06:06PM	Aquestive Therapeutics: Libervant Will Eventually Be Approved, Says Analyst TipRanks -11.27%
Sep-28-20 04:25AM	Aquestive Plunges 37% As FDA Rejects Seizure Drug; Street Stays Bullish SmarterAnalyst -34.69%
Sep-25-20 05:38PM	Aquestive Therapeutics Receives Complete Response Letter from FDA for Libervant (diazepam) Buccal Film for Management of Seizure Clusters GlobeNewswire
08:51AM	Implied Volatility Surging for Aquestive Therapeutics (AQST) Stock Options Zacks
Sep-17-20 10:11AM	3 Strong Buy Healthcare Stocks With Major Catalysts Approaching TipRanks +13.94%
Aug-20-20 08:11AM	Are Insiders Buying Aquestive Therapeutics, Inc. (NASDAQ:AQST) Stock? Simply Wall St.
07:30AM	Aquestive Therapeutics Initiates Phase 1 Pharmacokinetic Trial of AQST-108 (Sublingual Film Formulation Delivering Systemic Epinephrine) In Development for Treatment of Allergic Reactions Including Anaphylaxis GlobeNewswire
Aug-18-20 11:06AM	Aquestive Therapeutics (AQST) in Focus: Stock Moves 6.4% Higher Zacks +6.79%
Aug-10-20 07:30AM	Aquestive Therapeutics Receives FDA Fast Track Designation for AQST-108 (Sublingual Film Formulation Delivering Systemic Epinephrine) for Treatment of Allergic Reactions Including Anaphylaxis GlobeNewswire +10.49%
Aug-05-20 06:31PM	Aquestive Therapeutics, Inc. (AQST) Q2 2020 Earnings Call Transcript Motley Fool +7.83%
Aug-04-20 07:35PM	Aquestive Therapeutics (AQST) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:01PM	Aquestive Therapeutics Reports Second Quarter 2020 Financial Results and Provides Business Update: AQST-108 Progress Remains On Track; Libervant PDUFA Goal Date Approaches GlobeNewswire
08:18AM	The Daily Biotech Pulse: Voyager, AbbVie End Collaboration, Thumbs Down For DBV's Peanut Allergy Patch, Tiziana Expedites COVID-19 Trial Plans Benzinga
Jul-28-20 04:15PM	Aquestive Therapeutics to Present at 2020 Wedbush PacGrow Healthcare Virtual Conference GlobeNewswire
12:33PM	Aquestive Therapeutics (AQST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Jul-15-20 07:57AM	Aquestive Therapeutics to Announce Second Quarter Financial Results and Recent Business Highlights on Aug 4 and Host Conference Call on Aug 5 at 8:00 a.m. ET GlobeNewswire +6.18%
Jul-06-20 09:49AM	What Is The Ownership Structure Like For Aquestive Therapeutics, Inc. (NASDAQ:AQST)? Simply Wall St.
Jun-29-20 07:00AM	Aquestive Therapeutics Files IND for Pharmacokinetic Clinical Trials of AQST-108 (Sublingual Film Formulation Delivering Systemic Epinephrine) for Anaphylaxis Treatment GlobeNewswire
Jun-25-20 11:22AM	Hedge Funds Arent Crazy About Aquestive Therapeutics, Inc. (AQST) Anymore Insider Monkey
Jun-16-20 08:00AM	Aquestive Therapeutics to Present at BMO Capital Markets 2020 Prescriptions for Success Healthcare Conference GlobeNewswire
Jun-04-20 05:05PM	Aquestive Therapeutics to Hold Virtual-Only Annual Meeting of Stockholders GlobeNewswire
May-28-20 09:42AM	Implied Volatility Surging for Aquestive Therapeutics (AQST) Stock Options Zacks
May-27-20 09:22AM	Why Aquestive Therapeutics (AQST) Stock Might be a Great Pick Zacks
May-22-20 07:10AM	The Daily Biotech Pulse: FDA Nod For Aquestive, Tetraphase M&A Plot Thickens, Amarin's Vascepa In COVID Fray Benzinga -6.50%
May-21-20 05:27PM	Aquestive Therapeutics Advances Royalty Monetization Plan as Sunovion Pharmaceuticals Apomorphine Sublingual Film Therapy Receives FDA Approval GlobeNewswire
May-20-20 11:30AM	Is Aquestive Therapeutics (AQST) Outperforming Other Medical Stocks This Year? Zacks
May-14-20 08:25AM	Aquestive Therapeutics' Shares March Higher, Can It Continue? Zacks
May-12-20 12:00PM	All You Need to Know About Aquestive Therapeutics (AQST) Rating Upgrade to Buy Zacks
May-08-20 08:15AM	Benzinga Pro's Top 5 Stocks To Watch For Fri., May 8, 2020: KC, IDXX, LAZY, AQST, AN Benzinga +10.04%
May-07-20 02:00PM	Aquestive Therapeutics to Present at 2020 RBC Capital Markets Global Healthcare Conference GlobeNewswire +8.33%
May-06-20 06:00PM	Aquestive Therapeutics, Inc. (AQST) Q1 2020 Earnings Call Transcript Motley Fool
May-05-20 04:05PM	Aquestive Therapeutics Reports First Quarter 2020 Financial Results and Provides Business Update: AQST-108 and Libervant Remain On Track GlobeNewswire
Apr-28-20 12:34PM	Will Aquestive Therapeutics (AQST) Report Negative Earnings Next Week? What You Should Know Zacks
Apr-26-20 07:51AM	3 Biotech Stocks Under $4 With Big Upside Potential TipRanks
Apr-21-20 09:15AM	Aquestive Therapeutics to Announce First Quarter Financial Results and Recent Business Highlights on May 5 and Host Investment Community Conference Call on May 6 GlobeNewswire
Apr-15-20 08:50AM	Aquestive Therapeutics (AQST): Strong Industry, Solid Earnings Estimate Revisions Zacks
Apr-14-20 09:13AM	Top Ranked Momentum Stocks to Buy for April 14th Zacks +11.28%
Mar-17-20 07:00AM	Memgen Appoints Gregory Brown as Chief Executive Officer Newsfile +15.58%
Mar-14-20 08:15AM	Aquestive Therapeutics, Inc. Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock? Simply Wall St.
Mar-13-20 10:23AM	Company News for Mar 13, 2020 Zacks -12.50%
Mar-11-20 06:25PM	Aquestive Therapeutics (AQST) Reports Q4 Loss, Tops Revenue Estimates Zacks -14.53%
04:30PM	Aquestive Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Business Highlights GlobeNewswire
Mar-05-20 12:30PM	Will Aquestive Therapeutics (AQST) Report Negative Earnings Next Week? What You Should Know Zacks
Mar-03-20 03:00PM	7 Cheap Stocks Under $7 With Massive Upside Potential Kiplinger
Feb-20-20 07:00AM	Aquestive Therapeutics to Announce Fourth Quarter and Full Year 2019 Financial Results and Recent Business Highlights on March 12, 2020 GlobeNewswire
Feb-10-20 07:00AM	Aquestive Therapeutics Announces U.S. Food and Drug Administration Filing Acceptance of New Drug Application (NDA) for Libervant (diazepam) Buccal Film GlobeNewswire +17.93%
Feb-06-20 07:00AM	Aquestive Therapeutics Announces FDA Confirmed 505(b)(2) Pathway for AQST-108 (Sublingual Film Formulation Delivering Systemic Epinephrine) for Anaphylaxis Treatment GlobeNewswire
Jan-29-20 12:30PM	3 Healthcare Stocks That Can Double This Year TipRanks
Jan-12-20 06:16PM	Aquestive Therapeutics Receives FDA Response to Citizens Petition GlobeNewswire
Jan-10-20 06:30AM	Aquestive Therapeutics Exceeds Top End of Guidance Range for Preliminary Unaudited Full Year 2019 Total Revenues and Provides Initial Full Year 2020 Guidance GlobeNewswire
Dec-22-19 06:09PM	Did Hedge Funds Drop The Ball On Aquestive Therapeutics, Inc. (AQST) ? Insider Monkey
Dec-17-19 05:31AM	Did Changing Sentiment Drive Aquestive Therapeutics's (NASDAQ:AQST) Share Price Down By 22%? Simply Wall St.
Dec-12-19 08:00PM	Aquestive Therapeutics Announces Pricing of Public Offering of Common Stock GlobeNewswire -12.99%
Dec-11-19 07:21AM	The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly Misses Primary Endpoint Benzinga
Dec-10-19 04:01PM	Aquestive Therapeutics Announces Proposed Public Offering of Common Stock GlobeNewswire
Dec-09-19 10:04AM	Top Ranked Momentum Stocks to Buy for December 9th Zacks
Dec-04-19 08:30AM	Aquestive Therapeutics to Host Investor & Analyst Libervant (diazepam) Buccal Film Update Forum at American Epilepsy Society 2019 Annual Meeting GlobeNewswire
Dec-03-19 07:59AM	The Daily Biotech Pulse: Astellas To Buy Audentes For $3B, Applied Genetics Chief Medical Officer Quits, Axsome Aces Midstage Trial Benzinga
Dec-02-19 07:30AM	Aquestive Therapeutics Completes Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Libervant (diazepam) Buccal Film for Management of Seizure Clusters GlobeNewswire +12.20%
Nov-29-19 10:29AM	These 3 Biotech Stocks Could More Than Double in 2020, Says Wedbush TipRanks +7.15%
Nov-26-19 04:05PM	A Deep Dive Into Aquestive Following The FDA's Approval Of Riluzole Benzinga
11:27AM	Aquestive Therapeutics Announces Poster Presentations of Data on Libervant (diazepam) Buccal Film at American Epilepsy Society 2019 Annual Meeting GlobeNewswire
11:07AM	Company News For Nov 26, 2019 Zacks
Nov-25-19 08:56AM	Aquestive shares jump on FDA approval MarketWatch +17.26%
08:00AM	Aquestive Therapeutics Receives FDA Approval for Exservan (riluzole) Oral Film GlobeNewswire
Nov-24-19 04:19PM	The Week Ahead In Biotech: Aquestive Awaits FDA Decision, Arrowhead Earnings And More Benzinga
Nov-22-19 04:42PM	REFILE-FDA approves Aquestive's ALS treatment Reuters
Nov-14-19 01:31PM	Healthcare Drives Wall Street: 5 Soaring ETFs & Stocks Zacks
Nov-13-19 08:30AM	Aquestive Therapeutics Licenses Riluzole Oral Film to Zambon for Development and Commercialization in the EU for Patients with ALS GlobeNewswire
Nov-11-19 09:00AM	All You Need to Know About Aquestive Therapeutics (AQST) Rating Upgrade to Buy Zacks +10.83%
Nov-07-19 09:42AM	Company News for Nov 7, 2019 Zacks
Nov-05-19 06:35PM	Aquestive Therapeutics (AQST) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:50PM	Aquestive Therapeutics Reports Third Quarter 2019 Financial Results and Raises 2019 Guidance GlobeNewswire
Oct-30-19 10:33AM	Analysts Estimate Aquestive Therapeutics (AQST) to Report a Decline in Earnings: What to Look Out for Zacks
Oct-18-19 10:43AM	Have Insiders Been Buying Aquestive Therapeutics, Inc. (NASDAQ:AQST) Shares This Year? Simply Wall St.
Oct-16-19 07:06AM	The Daily Biotech Pulse: Akebia Sues CMS, Roche Raises Guidance Yet Again, Titan Medical Entangled In Credit Crunch Benzinga
Oct-15-19 05:41PM	Aquestive Therapeutics Reaffirms Full Year 2019 Revenue Guidance and Will Announce Third Quarter 2019 Financial Results and Recent Business Highlights on November 6, 2019 GlobeNewswire +5.03%
Sep-30-19 07:00AM	Aquestive Therapeutics Announces Successful Completion of Phase 1 Trial for AQST-108 (Sublingual Film Formulation Delivering Systemic Epinephrine) GlobeNewswire
Sep-03-19 03:25PM	Market Sentiment Around Loss-Making Aquestive Therapeutics, Inc. (NASDAQ:AQST) Simply Wall St.
Aug-30-19 06:00AM	There's Value In These 2 Small Beaten Down Biotech Stocks TheStreet.com -5.00%
Aug-26-19 08:30AM	Aquestive Therapeutics to Attend Two Upcoming Investor Conferences GlobeNewswire
Aug-06-19 08:05PM	Aquestive Therapeutics (AQST) Reports Q2 Loss, Tops Revenue Estimates Zacks
05:22PM	Aquestive Therapeutics Reports Second Quarter 2019 Financial Results and Recent Business Highlights GlobeNewswire
04:28PM	Aquestive Therapeutics Announces Positive Topline Results from Libervant (Diazepam) Buccal Film Single Dose Crossover Study GlobeNewswire
Jul-31-19 10:36AM	Will Aquestive Therapeutics (AQST) Report Negative Earnings Next Week? What You Should Know Zacks
Jul-29-19 11:45AM	Aquestive Therapeutics to Present at 2019 Wedbush PacGrow Healthcare Conference GlobeNewswire
Jul-18-19 02:23PM	Aquestive Therapeutics to Announce Second Quarter 2019 Financial Results and Recent Business Highlights on August 7, 2019 PR Newswire
Jul-17-19 01:38PM	What Percentage Of Aquestive Therapeutics, Inc. (NASDAQ:AQST) Shares Do Insiders Own? Simply Wall St.
Jul-15-19 04:35PM	Aquestive Therapeutics Completes $70 Million Debt Refinancing PR Newswire
Jun-07-19 08:30AM	Aquestive Therapeutics to Present at Two Upcoming Investor Conferences PR Newswire
Jun-04-19 08:00AM	Aquestive Therapeutics Completes Enrollment in Libervant (diazepam buccal film) Crossover Study PR Newswire
May-13-19 08:00AM	Aquestive Therapeutics to Present at Two Upcoming Investor Conferences PR Newswire -7.94%
May-08-19 07:31AM	Aquestive Therapeutics: 1Q Earnings Snapshot Associated Press -17.06%
07:00AM	IntelGenx and Aquestive Therapeutics Enter Worldwide Collaboration Agreement for Tadalafil GlobeNewswire
07:00AM	Aquestive Therapeutics Reports First Quarter 2019 Financial Results and Recent Business Highlights PR Newswire
May-07-19 07:00PM	Aquestive Therapeutics Announces Daniel Barber Named to Chief Operating Officer PR Newswire -6.20%
Apr-26-19 03:55PM	Need To Know: Aquestive Therapeutics, Inc. (NASDAQ:AQST) Insiders Have Been Buying Shares Simply Wall St.

Aquestive Therapeutics, Inc., a specialty pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; and Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery in the United States and internationally. Its proprietary product candidates comprise Libervant, a buccal soluble film formulation of diazepam for the treatment of recurrent epileptic seizures; and Exservan, an oral soluble film formulation of riluzole for the treatment of Amyotrophic Lateral Sclerosis. The company's proprietary pipeline of complex molecule products include AQST-108, a sublingual film formulation of epinephrine for the treatment of anaphylaxis; and AQST-305, a sublingual film formulation of octreotide for the treatment of acromegaly and neuroendocrine tumors. It also develops AQST-119, an oral soluble film formulation of tadalafil for the treatment of erectile dysfunction; and APL-130277, a sublingual film using apomorphine to treat parkinson's disease. Aquestive Therapeutics, Inc. was founded in 2004 and is headquartered in Warren, New Jersey.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Maxwell John T.	SVP-Chief Financial Officer	Aug 18	Sale	8.00	3,000	24,000	150,614	Aug 19 08:55 AM
Kendall Keith J	CEO and President	Jun 30	Option Exercise	0.00	333	0	639,297	Jul 02 04:00 PM
Schobel Alexander Mark	Chief Innovation/Tech Officer	Jun 30	Option Exercise	0.00	333	0	912,886	Jul 02 04:00 PM
Kendall Keith J	CEO and President	Jun 04	Sale	5.11	50,000	255,310	638,964	Jun 05 04:05 PM
Schobel Alexander Mark	Chief Innovation/Tech Officer	May 31	Option Exercise	0.00	14,572	0	916,685	Jun 02 05:14 PM
Kendall Keith J	CEO and President	May 31	Option Exercise	0.00	14,572	0	695,456	Jun 02 05:13 PM
Schobel Alexander Mark	Chief Innovation/Tech Officer	May 08	Sale	5.00	40,000	200,000	902,113	May 11 04:15 PM
Schobel Alexander Mark	Chief Innovation/Tech Officer	Apr 29	Sale	4.50	40,000	180,000	1,022,113	May 01 04:05 PM
Schobel Alexander Mark	Chief Innovation/Tech Officer	Apr 27	Sale	4.00	40,000	160,000	942,113	May 04 04:05 PM
Schobel Alexander Mark	Chief Innovation/Tech Officer	Apr 14	Sale	3.70	40,000	148,000	982,113	May 04 04:05 PM
Schobel Alexander Mark	Chief Innovation/Tech Officer	Mar 31	Option Exercise	0.00	329	0	1,062,210	Apr 02 04:16 PM
Kendall Keith J	CEO and President	Mar 31	Option Exercise	0.00	329	0	680,983	Apr 02 04:16 PM
BRAENDER LORI J	SVP, General Counsel	Mar 16	Buy	1.54	14,000	21,624	25,000	Mar 18 04:45 PM
Boyd Peter E.	SVP-Bus. Process & Info. Tech.	Mar 16	Buy	1.50	2,000	3,000	52,239	Mar 18 04:45 PM
Kendall Keith J	CEO and President	Feb 29	Option Exercise	0.00	14,572	0	685,383	Mar 03 07:37 PM
Schobel Alexander Mark	Chief Innovation/Tech Officer	Feb 29	Option Exercise	0.00	14,572	0	1,066,947	Mar 03 07:38 PM
Schobel Alexander Mark	Chief Innovation/Tech Officer	Dec 31	Option Exercise	0.00	329	0	1,044,494	Jan 02 04:15 PM
Kendall Keith J	CEO and President	Dec 31	Option Exercise	0.00	329	0	662,985	Jan 02 02:04 PM
Kendall Keith J	CEO and President	Nov 30	Option Exercise	0.00	14,572	0	677,228	Dec 02 04:56 PM
Schobel Alexander Mark	Chief Innovation/Tech Officer	Nov 30	Option Exercise	0.00	14,572	0	1,058,737	Dec 02 04:56 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience